Ptc Therapeutics (PTCT) Deferred Taxes (2016 - 2026)
Ptc Therapeutics' (PTCT) quarterly Deferred Taxes came in at -$10000.0 in Q1 2026, down 600.0% year-on-year from $2000.0 in Q1 2025, and down 1100.0% quarter-over-quarter from $1000.0 in Q4 2025.
Ptc Therapeutics (PTCT) Deferred Taxes (2016 - 2026) Analysis & Trends
Ptc Therapeutics' Deferred Taxes history runs 6 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- On a quarterly basis, Deferred Taxes fell 600.0% year-over-year to -$10000.0 in Q1 2026; TTM through Mar 2026 was -$55.9 million, a 0.01% change from a year earlier, with the FY2025 full-year figure at -$3000.0, up 99.99% from the prior year.
- Deferred Taxes retreated to -$10000.0 in Q1 2026 per PTCT's latest filing, from $1000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $4.0 million in Q4 2023 and bottomed at -$55.9 million in Q4 2024.
- The 4-year median for Deferred Taxes is -$2000.0 (2023), against an average of -$9.3 million.
- Across the five-year window, Deferred Taxes plunged 1505.13% in 2024 and soared 300.0% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at $4.0 million in 2023, then plunged by 1505.13% to -$55.9 million in 2024, then soared by 100.0% to $1000.0 in 2025, then tumbled by 1100.0% to -$10000.0 in 2026.
- Per Business Quant, the three latest PTCT Deferred Taxes figures stand at -$10000.0 (Q1 2026), $1000.0 (Q4 2025), and $2000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -55.91 Mn |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 3.98 Mn |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -50.90 Mn |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2017 | 199,000.00 |
| Dec 31, 2016 | 23,000.00 |
| Sep 30, 2016 | 22,000.00 |